These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 30415025)
21. The metabolic syndrome, diabetes, and Alzheimer's disease. García-Lara JM; Aguilar-Navarro S; Gutiérrez-Robledo LM; Avila-Funes JA Rev Invest Clin; 2010; 62(4):343-9. PubMed ID: 21218671 [TBL] [Abstract][Full Text] [Related]
22. The Trojan horse - neuroinflammatory impact of T cells in neurodegenerative diseases. Sommer A; Winner B; Prots I Mol Neurodegener; 2017 Oct; 12(1):78. PubMed ID: 29078813 [TBL] [Abstract][Full Text] [Related]
23. Validating the role of the Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) and a genetic risk score in progression to cognitive impairment in a population-based cohort of older adults followed for 12 years. Andrews SJ; Eramudugolla R; Velez JI; Cherbuin N; Easteal S; Anstey KJ Alzheimers Res Ther; 2017 Mar; 9(1):16. PubMed ID: 28259165 [TBL] [Abstract][Full Text] [Related]
24. Exploring the role of physical activity and exercise for managing vascular comorbidities in people with multiple sclerosis: A scoping review. Ewanchuk BW; Gharagozloo M; Peelen E; Pilutti LA Mult Scler Relat Disord; 2018 Nov; 26():19-32. PubMed ID: 30216755 [TBL] [Abstract][Full Text] [Related]
25. 2003-2013: a decade of body mass index, Alzheimer's disease, and dementia. Emmerzaal TL; Kiliaan AJ; Gustafson DR J Alzheimers Dis; 2015; 43(3):739-55. PubMed ID: 25147111 [TBL] [Abstract][Full Text] [Related]
26. A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview. Marrie RA; Cohen J; Stuve O; Trojano M; Sørensen PS; Reingold S; Cutter G; Reider N Mult Scler; 2015 Mar; 21(3):263-81. PubMed ID: 25623244 [TBL] [Abstract][Full Text] [Related]
27. Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias. Allan LM; Ballard CG; Burn DJ; Kenny RA J Am Geriatr Soc; 2005 Oct; 53(10):1681-7. PubMed ID: 16181166 [TBL] [Abstract][Full Text] [Related]
28. Is the Use of Proton-pump Inhibitors a Risk Factor for Alzheimer's Disease? Molecular Mechanisms and Clinical Implications. Ide K; Matsuoka N; Kawakami K Curr Med Chem; 2018; 25(18):2166-2174. PubMed ID: 29376492 [TBL] [Abstract][Full Text] [Related]
29. Risk and protective factors for sporadic Alzheimer's disease. Stozická Z; Zilka N; Novák M Acta Virol; 2007; 51(4):205-22. PubMed ID: 18197729 [TBL] [Abstract][Full Text] [Related]
30. Neuroinflammatory challenges compromise neuronal function in the aging brain: Postoperative cognitive delirium and Alzheimer's disease. Cortese GP; Burger C Behav Brain Res; 2017 Mar; 322(Pt B):269-279. PubMed ID: 27544872 [TBL] [Abstract][Full Text] [Related]
31. Distribution of disease courses in familial vs sporadic multiple sclerosis. Steenhof M; Nielsen NM; Stenager E; Kyvik K; Möller S; Hertz JM Acta Neurol Scand; 2019 Mar; 139(3):231-237. PubMed ID: 30412642 [TBL] [Abstract][Full Text] [Related]
32. The Prevalence and Incidence of Dementia Due to Alzheimer's Disease: a Systematic Review and Meta-Analysis. Fiest KM; Roberts JI; Maxwell CJ; Hogan DB; Smith EE; Frolkis A; Cohen A; Kirk A; Pearson D; Pringsheim T; Venegas-Torres A; Jetté N Can J Neurol Sci; 2016 Apr; 43 Suppl 1():S51-82. PubMed ID: 27307128 [TBL] [Abstract][Full Text] [Related]
33. Comparison of predictors of hip fracture and mortality after hip fracture in community-dwellers with and without Alzheimer's disease - exposure-matched cohort study. Tolppanen AM; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S BMC Geriatr; 2016 Dec; 16(1):204. PubMed ID: 27908278 [TBL] [Abstract][Full Text] [Related]
34. Neuroinflammation as a Common Mechanism Associated with the Modifiable Risk Factors for Alzheimer's and Parkinson's Diseases. McKenzie JA; Spielman LJ; Pointer CB; Lowry JR; Bajwa E; Lee CW; Klegeris A Curr Aging Sci; 2017; 10(3):158-176. PubMed ID: 28302047 [TBL] [Abstract][Full Text] [Related]